Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (NSERC) (261311-2013)
- Research Manitoba Graduate Studentship and the Canadian Breast Cancer Foundation
This publication has 39 references indexed in Scilit:
- Cancer stem cells and chemoresistance: The smartest survives the raidPharmacology & Therapeutics, 2016
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Nature as a remarkable chemistAnti-Cancer Drugs, 2014
- Targeting tumour-supportive cellular machineries in anticancer drug developmentNature Reviews Drug Discovery, 2014
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008International Journal of Cancer, 2012
- The Valley of Death in anticancer drug development: a reassessmentTrends in Pharmacological Sciences, 2012
- Drug therapy of cancerEuropean Journal of Clinical Pharmacology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- The clinical use of mutagenic anticancer drugsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996